Type III hyperlipoproteinemia with xanthomas and multiple myeloma

Journal of the American Academy of Dermatology

Volumn 53, Issue 5 SUPPL., 2005, Pages

  Burnside, Nancy J ^a   Alberta, Lauren ^b   Robinson Bostom, Leslie ^a   Bostom, Andrew ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN A ANTIBODY; MELPHALAN; PREDNISONE; VERY LOW DENSITY LIPOPROTEIN; VINCRISTINE;

AGED; ANAMNESIS; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DYSLIPIDEMIA; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN METABOLISM; XANTHOMA;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; COMORBIDITY; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HISTIOCYTES; HUMANS; HYPERLIPOPROTEINEMIA TYPE III; IMMUNOGLOBULIN A; LIPOPROTEINS, VLDL; MALE; MELPHALAN; MULTIPLE MYELOMA; PHENOTYPE; PREDNISONE; XANTHOMATOSIS;

EID: 26644471017     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.04.009     Document Type: Article

References (27)

1. R.W. Mahley, and S.C. Rall Jr. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The metabolic and molecular bases of inherited diseases 7th ed. 1995 McGraw-Hill New York 1953 1980
2. M.S. Doutre, C. Conri, C. Beylot, B. Fleury, H. Chapoulard, and P. Bioulac Normolipemic plane xanthomas and IgGk myeloma with anti-lipoprotein activity: apropos of a case, review of the literature [French] Dermatologica 170 1985 157 164
3. K.R. Feingold, G.R. Castro, Y. Ishikawa, P.E. Fielding, and C.J. Fielding Cutaneous xanthoma in association with paraproteinemia in the absence of hyperlipidemia J Clin Invest 83 1989 796 802
4. P. Lepeytre, B. Chanu, M. Seligmann, and P. Morel Normolipemic plane xanthoma - IgG kappa myeloma - lupus erythematosus [French] Ann Dermatol Venereol 112 1985 737 738
5. J.C. Maize, A.R. Ahmed, and T.T. Provost Xanthoma disseminatum and multiple myeloma Arch Dermatol 110 1974 758 761
6. P. Meunier, I. Gorin, A. Delmer, and J.P. Escande Diffuse normolipidemic plane xanthomatosis and monoclonal dysglobulinemia: a case with anti-lipoprotein activity of monoclonal immunoglobulin and hypocomplementemia [French] Ann Dermatol Venereol 123 1996 93 95
7. R. Piccinno, S. Menni, S. Cavicchini, and R. Gianotti Normolipemic plane xanthomas and IgG-k multiple myeloma: description of a clinical case [Italian] G Ital Dermatol Venereol 125 1990 449 451
8. J.L. Beaumont, B. Jacotot, C. Vilain, and V. Beaumont Myeloma, hyperlipidemia and xanthomatosis: a syndrome due to the presence of an anti-beta-lipoprotein autoantibody [French] Nouv Rev Fr Hematol 5 1965 787 792
9. G. Chelazzi, and R. Uccella Hyperlipidemia and xanthomatosis in the course of multiple myeloma: review of the literature and presentation of a case [author's translation] [Spanish] Sangre 19 1974 295 300
10. M. Cloarec, J. Etienne, and J. Debray Association of myeloma and hyperlipidemia with xanthomatous eruption [French] Sem Hop 48 1972 3459 3466
11. C. Cortese, B. Lewis, N.E. Miller, M.A. Peyman, S.N. Rao, and B. Slavin Myelomatosis with type III hyperlipoproteinemia: clinical and metabolic studies N Engl J Med 307 1982 79 83
12. L.I. Dvoretskii, O.P. Kuznetsova, E.A. Pustynskaia, and G.N. Tikhonova A combination of myelomatous disease with generalized xanthomatosis [Russian] Ter Arkh 64 1992 114 115
13. S.J. Friedman, and T.W. Martin Xanthoma striatum palmare associated with multiple myeloma J Am Acad Dermatol 116 1987 1272 1274
14. B. Grosbois, D. Baudet, L. Loncle, V. Lebouquin, R. Lauvin, and D. Jacomy Necrobiotic xanthogranulomatosis disclosing multiple myeloma [French] Ann Med Interne (Paris) 141 1990 286 288
15. M. Hagiyama, T. Arima, J. Arata, K. Namba, M. Murakami, and M. Inamizu Polymorphic type of xanthomatosis in association with IgA myeloma J Dermatol 9 1982 347 354
16. Y.K. Keung, C. Yung, J.W. Wong, F. Shah, and E. Cobos Association of temporal arteritis, retinal vasculitis, and xanthomatosis with multiple myeloma: case report and literature review Mayo Clin Proc 73 1998 657 660
17. J.E. Lennard-Jones Myelomatosis with lipaemia and xanthomata Br Med J 5175 1960 781 783
18. W.C. Levin, M.H. Aboumrad, S.E. Ritzmann, and C. Brantly Gamma-type I myeloma and xanthomatosis Arch Intern Med 114 1964 688 693
19. L. Aubert, H. Arroyo, P. Detolle, D. Picard, and G. Cotte Clinical and cytologic study of a 2nd case of xanthomatous IgA myeloma with circulating anti-lipoprotein antibodies [French] Sem Hop 43 1967 3014 3021
20. W. James III, and W.R. Harland Plasma cell disease and xanthomatosis Trans Am Clin Climatol Assoc 79 1968 115 123
21. S.L. Moschella Xanthomatosis associated with multiple myeloma Arch Dermatol 102 1970 121 123
22. H. Kodama, S. Nakagawa, and K. Tanioku Plane xanthomatosis with antilipoprotein autoantibody Arch Dermatol 105 1972 722 727
23. K.J. Marien, and G. Smeenk Generalized planar xanthomata associated with multiple myeloma and hyperlipoproteinemia Arch Belg Dermatol 29 1973 317 318
24. L.A. Lewis, V.G. deWolfe, A. Butkus, and I.H. Page Autoimmune hyperlipidemia in a patient: atherosclerotic course and changing immunoglobulin pattern during 21 years of study Am J Med 59 1975 208 218
25. J.S. Taylor, L.A. Lewis, J.D. Battle Jr., A. Butkus, A.L. Robertson, and S. Deodhar Plane xanthoma and multiple myeloma with lipoprotein-paraprotein complexing Arch Dermatol 114 1978 425 431
26. M.F. Baudet, C. Dachet, and J.L. Beaumont Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa Clin Exp Immunol 39 1980 455 460
27. L.L. Kilgore, B.W. Patterson, D.M. Parenti, and W.R. Fisher Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma: characterization of this immunoglobulin J Clin Invest 76 1985 225 232